118 related articles for article (PubMed ID: 12030837)
1. Automated in vitro screening of teratogens.
Walmod PS; Berezin A; Gallagher HC; Gravemann U; Lepekhin EA; Belman V; Bacon CL; Nau H; Regan CM; Berezin V; Bock E
Toxicol Appl Pharmacol; 2002 May; 181(1):1-15. PubMed ID: 12030837
[TBL] [Abstract][Full Text] [Related]
2. Discriminative power of an assay for automated in vitro screening of teratogens.
Walmod PS; Gravemann U; Nau H; Berezin V; Bock E
Toxicol In Vitro; 2004 Aug; 18(4):511-25. PubMed ID: 15130609
[TBL] [Abstract][Full Text] [Related]
3. Molecular multiple endpoint embryonic stem cell test--a possible approach to test for the teratogenic potential of compounds.
zur Nieden NI; Kempka G; Ahr HJ
Toxicol Appl Pharmacol; 2004 Feb; 194(3):257-69. PubMed ID: 14761682
[TBL] [Abstract][Full Text] [Related]
4. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
Lampen A; Göttlicher M; Nau H
ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
[TBL] [Abstract][Full Text] [Related]
5. New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta).
Lampen A; Siehler S; Ellerbeck U; Göttlicher M; Nau H
Toxicol Appl Pharmacol; 1999 Nov; 160(3):238-49. PubMed ID: 10544058
[TBL] [Abstract][Full Text] [Related]
6. Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues.
Walmod PS; Foley A; Berezin A; Ellerbeck U; Nau H; Bock E; Berezin V
Cell Motil Cytoskeleton; 1998; 40(3):220-37. PubMed ID: 9678666
[TBL] [Abstract][Full Text] [Related]
7. Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo.
Selderslaghs IW; Van Rompay AR; De Coen W; Witters HE
Reprod Toxicol; 2009 Nov; 28(3):308-20. PubMed ID: 19447169
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test.
Peters AK; Steemans M; Hansen E; Mesens N; Verheyen GR; Vanparys P
Toxicol Sci; 2008 Oct; 105(2):342-50. PubMed ID: 18593728
[TBL] [Abstract][Full Text] [Related]
9. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
Festag M; Viertel B; Steinberg P; Sehner C
Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
[TBL] [Abstract][Full Text] [Related]
10. ReProGlo: a new stem cell-based reporter assay aimed to predict embryotoxic potential of drugs and chemicals.
Uibel F; Mühleisen A; Köhle C; Weimer M; Stummann TC; Bremer S; Schwarz M
Reprod Toxicol; 2010 Aug; 30(1):103-12. PubMed ID: 20018237
[TBL] [Abstract][Full Text] [Related]
11. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test.
Seiler A; Visan A; Buesen R; Genschow E; Spielmann H
Reprod Toxicol; 2004; 18(2):231-40. PubMed ID: 15019721
[TBL] [Abstract][Full Text] [Related]
12. The teratogenic potencies of valproic acid derivatives and their effects on biological end-points are related to changes in histone deacetylase and Erk1/2 activities.
Gotfryd K; Hansen M; Kawa A; Ellerbeck U; Nau H; Berezin V; Bock E; Walmod PS
Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):164-74. PubMed ID: 21439023
[TBL] [Abstract][Full Text] [Related]
13. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
Gravemann U; Volland J; Nau H
Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
[TBL] [Abstract][Full Text] [Related]
14. A short-term screening test for teratogens using differentiating neuroblastoma cells in vitro.
Mummery CL; van den Brink CE; van der Saag PT; de Laat SW
Teratology; 1984 Apr; 29(2):271-9. PubMed ID: 6740511
[TBL] [Abstract][Full Text] [Related]
15. Multiple effects of pentyl-4-yn-VPA enantiomers: from toxicity to short-term memory enhancement.
Gotfryd K; Owczarek S; Hoffmann K; Klementiev B; Nau H; Berezin V; Bock E; Walmod PS
Neuropharmacology; 2007 Mar; 52(3):764-78. PubMed ID: 17095022
[TBL] [Abstract][Full Text] [Related]
16. An automatic procedure for evaluation of single cell motility.
Dmytriyev A; Tkach V; Rudenko O; Bock E; Berezin V
Cytometry A; 2006 Sep; 69(9):979-85. PubMed ID: 16969795
[TBL] [Abstract][Full Text] [Related]
17. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
18. Assessing developmental osteotoxicity of chlorides in the embryonic stem cell test.
zur Nieden NI; Baumgartner L
Reprod Toxicol; 2010 Sep; 30(2):277-83. PubMed ID: 20447454
[TBL] [Abstract][Full Text] [Related]
19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
20. [Innovative cell culture methods in drug development].
Schleger C; Krebsfaenger N; Kalkuhl A; Bader R; Singer T
ALTEX; 2001; 18(1):5-8. PubMed ID: 11248842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
